Literature DB >> 25089595

Deferrals of volunteer stem cell donors referred for evaluation for matched-unrelated stem cell donation.

S Bräuninger1, K Thorausch1, B Luxembourg1, M Schulz1, K U Chow2, E Seifried3, H Bonig4.   

Abstract

To minimize donor risk and maintain public support, volunteer donor stem cell donation, whether by mobilized leukapheresis or marrow aspiration, requires careful donor eligibility assessment. Many contraindications to stem cell donation exist, yet analyses of donor deferral rates are not available. In a 36-month series encompassing 2493 potential stem cell donors, we analyzed frequencies and reasons for deferrals. All were presumed eligible by their registries because of previously submitted structured health questionnaire and formal telephone interviews. After assessment by our center's physicians, 3.3% of donors proved ineligible, but 5.6% more were eligible for only one of the collection methods. Higher deferral rates were associated with female sex, increasing age and mobilized stem cell donation vs marrow. Exclusion criteria were identified with approximately similar frequency by medical history, physical examination and laboratory testing. Reasons for deferrals almost exclusively served to protect donor safety; the rare recipient-directed safety concerns could be, and often were, overridden in agreement with the transplant center. As formal analyses have shown, with careful assessment, stem cell donation is acceptably safe, but the plethora of deferral reasons mandate that only physicians with specific experience should evaluate stem cell donors, that is, this task should not be delegated to paramedical personnel.

Entities:  

Mesh:

Year:  2014        PMID: 25089595     DOI: 10.1038/bmt.2014.171

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  28 in total

1.  Hematopoietic stem cell transplantation: a global perspective.

Authors:  Alois Gratwohl; Helen Baldomero; Mahmoud Aljurf; Marcelo C Pasquini; Luis Fernando Bouzas; Ayami Yoshimi; Jeff Szer; Jeff Lipton; Alvin Schwendener; Michael Gratwohl; Karl Frauendorfer; Dietger Niederwieser; Mary Horowitz; Yoshihisa Kodera
Journal:  JAMA       Date:  2010-04-28       Impact factor: 56.272

2.  Adverse reactions in whole blood donors: an Indian scenario.

Authors:  Chintamani Pathak; Meenu Pujani; Sangeeta Pahuja; Manjula Jain
Journal:  Blood Transfus       Date:  2010-09-07       Impact factor: 3.443

Review 3.  G-CSF in Healthy Allogeneic Stem Cell Donors.

Authors:  Kristina Hölig
Journal:  Transfus Med Hemother       Date:  2013-07-22       Impact factor: 3.747

4.  Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors.

Authors:  Kristina Hölig; Michael Kramer; Frank Kroschinsky; Martin Bornhäuser; Thilo Mengling; Alexander H Schmidt; Claudia Rutt; Gerhard Ehninger
Journal:  Blood       Date:  2009-08-07       Impact factor: 22.113

5.  Donor Deferral Rates after the Implementation of a New German Blood Donor Questionnaire.

Authors:  Michael Müller-Steinhardt; Christian Weidmann; Markus Wiesneth; Eberhard Weck; Erhard Seifried; Joachim Brade; Harald Klüter
Journal:  Transfus Med Hemother       Date:  2011-12-23       Impact factor: 3.747

6.  Acute iritis induced by granulocyte colony-stimulating factor used for mobilization in a volunteer unrelated peripheral blood progenitor cell donor.

Authors:  T Parkkali; L Volin; M K Sirén; T Ruutu
Journal:  Bone Marrow Transplant       Date:  1996-03       Impact factor: 5.483

Review 7.  Sex differences in autoimmune disease from a pathological perspective.

Authors:  DeLisa Fairweather; Sylvia Frisancho-Kiss; Noel R Rose
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

8.  Donor deferral and resulting donor loss at the American Red Cross Blood Services, 2001 through 2006.

Authors:  Shimian Zou; Fatemeh Musavi; Edward P Notari; Jorge A Rios; Jonathan Trouern-Trend; Chyang T Fang
Journal:  Transfusion       Date:  2008-08-20       Impact factor: 3.157

9.  Allele frequency distribution of 1691G >A F5 (which confers Factor V Leiden) across Europe, including Slavic populations.

Authors:  Jeremy S C Clark; Grażyna Adler; Nermin N Salkic; Andrzej Ciechanowicz
Journal:  J Appl Genet       Date:  2013-11       Impact factor: 3.240

10.  Hematopoietic SCT in Europe: data and trends in 2011.

Authors:  J R Passweg; H Baldomero; M Bregni; S Cesaro; P Dreger; R F Duarte; J H F Falkenburg; N Kröger; D Farge-Bancel; H Bobby Gaspar; J Marsh; M Mohty; C Peters; A Sureda; A Velardi; C Ruiz de Elvira; A Madrigal
Journal:  Bone Marrow Transplant       Date:  2013-04-15       Impact factor: 5.483

View more
  6 in total

1.  Automation of cellular therapy product manufacturing: results of a split validation comparing CD34 selection of peripheral blood stem cell apheresis product with a semi-manual vs. an automatic procedure.

Authors:  Christiane Hümmer; Carolin Poppe; Milica Bunos; Belinda Stock; Eva Wingenfeld; Volker Huppert; Juliane Stuth; Kristina Reck; Mike Essl; Erhard Seifried; Halvard Bonig
Journal:  J Transl Med       Date:  2016-03-16       Impact factor: 5.531

2.  Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 (balixafortide) in healthy volunteers-results of a dose escalation trial.

Authors:  Darja Karpova; Susanne Bräuninger; Eliza Wiercinska; Ariane Krämer; Belinda Stock; Jochen Graff; Hans Martin; Achim Wach; Christophe Escot; Garry Douglas; Barbara Romagnoli; Eric Chevalier; Klaus Dembowski; Leon Hooftman; Halvard Bonig
Journal:  J Transl Med       Date:  2017-01-03       Impact factor: 5.531

3.  Erythrocyte depletion from bone marrow: performance evaluation after 50 clinical-scale depletions with Spectra Optia BMC.

Authors:  Soo-Zin Kim-Wanner; Gesine Bug; Juliane Steinmann; Salem Ajib; Nadine Sorg; Carolin Poppe; Milica Bunos; Eva Wingenfeld; Christiane Hümmer; Beate Luxembourg; Erhard Seifried; Halvard Bonig
Journal:  J Transl Med       Date:  2017-08-11       Impact factor: 5.531

4.  Donor-intrinsic variables determine mobilization efficiency: analyses from a cohort of sixty twice-mobilized stem cell donors.

Authors:  Soo-Zin Kim-Wanner; Seo-Youn Lee; Erhard Seifried; Halvard Bonig
Journal:  J Transl Med       Date:  2020-12-18       Impact factor: 5.531

5.  Generation and validation of a formula to calculate hemoglobin loss on a cohort of healthy adults subjected to controlled blood loss.

Authors:  Max Hahn-Klimroth; Philipp Loick; Soo-Zin Kim-Wanner; Erhard Seifried; Halvard Bonig
Journal:  J Transl Med       Date:  2021-03-20       Impact factor: 5.531

6.  Superior physical and mental health of healthy volunteers before and five years after mobilized stem cell donation.

Authors:  J Heyn; S Bräuninger; M Dimova-Dobreva; N Mathieson; N Koptelova; A Kolpakova; C Seidl; P Reinhardt; C Tsamadou; H Schrezenmeier; R Nakov; E Seifried; H Bonig
Journal:  J Transl Med       Date:  2022-03-14       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.